Deciphering the Immune–Tumor Interplay During Early-Stage Lung Cancer Development via Single-Cell Technology

Lung cancer is the leading cause of cancer-related death worldwide. Cancer immunotherapy has shown great success in treating advanced-stage lung cancer but has yet been used to treat early-stage lung cancer, mostly due to lack of understanding of the tumor immune microenvironment in early-stage lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wei-Wei, Liu, Wei, Li, Yingze, Wang, Jun, Ren, Yijiu, Wang, Guangsuo, Chen, Chang, Li, Hanjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761635/
https://www.ncbi.nlm.nih.gov/pubmed/35047383
http://dx.doi.org/10.3389/fonc.2021.716042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761635/
https://www.ncbi.nlm.nih.gov/pubmed/35047383
http://dx.doi.org/10.3389/fonc.2021.716042

Ejemplares similares